#ESCCongress – [Abstract Only] Randomized Trial: Angiotensin–Neprilysin Inhibition Not Beneficial for Heart Failure with Preserved Ejection Fraction

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: PARAGON-HF: Sacubitril-Valsartan in HFpEF Patients Did Not Result in Significantly Lower Rates of Hospitalizations, Death – American College of Cardiology (free)

Related Commentary on Twitter

#PARAGON-HF released!#ESCCongress Sacubitril–valsartan did not result in a significantly lower rate of total hospitalizations for heart failure & death from CV causes among patients with heart failure and an ejection fraction of >|=45%
? https://t.co/Q7rwiDyLT4… pic.twitter.com/ktumqXFrO8

— Dr. Martha Gulati (@DrMarthaGulati) September 1, 2019